velafermin
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2005 (NCT00104065)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- KlothoAGONIST
KL agonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108059 ↗
Also known as
- cg53135
- cg53135
- cg-53135-05
- fgf-20 protein, human
- fgf20 protein, human
- fibroblast growth factor 20, human
- velafermin
- velafermin
- velafermin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00323518 | Phase 2 | May 1, 2006 | CuraGen |
| NCT00104065 | Phase 2 | Jan 1, 2005 | CuraGen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CuraGen | For profit | 2 | 2 | 1 | 2005 |
1 organizations
Page 1 / 1